What this article helps you consider
- Identify the applicable framework
- Map plausible sources
- Calculate exposure on a consistent basis
Identify the applicable framework
ICH Q3D provides a risk-based framework for elemental impurities in medicines within its scope, including route-specific permitted daily exposures. It is not a universal contaminant standard for all foods, supplements or botanical materials. Products outside its scope require their own category- and market-specific assessment. R20R21
For a nutraceutical marketed in India, establish the relevant FSSAI provisions and applicable ingredient or product specifications. Do not assume that meeting a pharmaceutical elemental impurity calculation demonstrates compliance with food contaminant limits. Some requirements are concentration-based, while exposure-based evaluations depend on the maximum daily amount consumed.
Map plausible sources
Review intentionally added catalysts, raw materials, excipients, water, processing equipment and packaging. Natural or mineral-derived ingredients may introduce variability associated with their source and processing. Equipment contribution can depend on corrosion, contact conditions and cleaning. The assessment should explain why an element is relevant or why its contribution is considered unlikely.
Supplier certificates are useful when they describe representative lots, suitable methods and meaningful limits. A broad statement that material is free from heavy metals is insufficiently specific. Identify the named elements, reporting limits, sampling basis and any relevant supplier or process changes.
Calculate exposure on a consistent basis
For each relevant element, combine its concentration with the maximum daily mass of product or each component. If a hypothetical product contains 0.30 micrograms per gram of an element and the maximum daily product intake is 4 g, the calculated exposure is 1.2 micrograms per day. Compare this with the appropriate product-specific criterion; no safety conclusion follows from the arithmetic alone.
For a formulation assembled from several ingredients, sum their contributions on the same unit basis. An ingredient present at low concentration can still be an important contributor if used at high mass. The illustration illustrates this principle using invented ingredient contributions and an unnamed element. It contains no regulatory limit.
Contributions from an unnamed element. No regulatory limit or safety conclusion. The complete product, daily dose and applicable framework determine the comparison.
View the calculation
0.55 + 0.30 + 0.20 + 0.15 = 1.20 micrograms per day.
For each source: concentration (µg/g) × daily mass (g/day) = exposure (µg/day).
Select a fit for purpose method
Inductively coupled plasma mass spectrometry is useful for many trace-element determinations, but performance depends on digestion, contamination control and management of spectral and matrix interferences. Demonstrate recovery using suitable reference materials, spikes or complementary approaches appropriate to the matrix and analytes.
A clear digest is not proof of complete recovery. Some analytes may be lost during preparation, while resistant matrices may require different digestion conditions. Include blanks, appropriate internal standards and checks at concentrations relevant to the control decision. Where a requirement concerns a particular chemical species, a total-element result may not answer the regulatory question.
Use evidence to establish controls
Characterisation data can support material controls, supplier qualification, periodic monitoring or routine finished-product testing. The chosen strategy should address variability and uncertainty as well as average measured levels. A small set of favourable batches may be inadequate if a natural-source ingredient varies substantially across origin or season.
Define events that trigger reassessment, such as a new supplier, altered catalyst, equipment change or increased daily dose. The initial assessment remains useful only while its assumptions continue to describe the product.
Document the decision
A defensible report connects source assessment, analytical results, exposure calculations and the selected control measures. Record the origin of each numerical limit and whether it is a pharmaceutical exposure value, a food contaminant limit or an internal specification. This avoids apparently precise calculations built on the wrong regulatory basis.
Stabicon can support analytical testing and the interpretation of material and product data within a clearly defined project scope, helping clients select controls proportionate to their actual elemental impurity risks.
References & further reading
Read the source in its stated scope. Requirements, amendments and compendial editions depend on the product and target market. Draft guidance is identified separately.
- R20ICH Q3D R2 Elemental Impurities
EMA current-effective-version page. Pharmaceutical scope, risk assessment and route-specific exposure.
- R21FSSAI Health Supplements and Nutraceuticals Standards
Official regulations portal. Verify current amendments, permitted ingredients, levels and category-specific requirements.
- R14FSSAI Food Safety Management Systems Guidance for Food Supplements
Guidance document, 2018. Practical food-supplement manufacturing and hygiene context; not a replacement for current regulations.
From insight to a defined programme
Bring your next technical question.
Share your formulation, testing objective or development challenge. Stabicon can review the context and define a suitable scope of work.
Discuss this topic with Stabicon






